FACTOR II ALONE OR IN COMBINATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11761051.9

公开号：

EP2624859B1

申请日:

2011.09.19

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII (2) PCC and (3) a three factor combination of FH, FX and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/